GGrantIndex
← Leaderboards

Jordan D Miller

University Of Iowa

$6,555,014
Attributed
$9,664,456
Total exposure
8
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.6M · FY200621
$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21

Funding mix

By agency

NIH$9,664,456 · 8

By mechanism

R01$5,556,085 · 3
UH3$2,018,643 · 1
UH2$1,151,147 · 1
R00$746,996 · 1
K99$107,190 · 1
F32$84,395 · 1

Top collaborators

Most similar at University Of Iowa

Same institution · by research overlap

Others in their field

Top investigators on “Cells

Research focus

CellsAttenuatedOperative Surgical ProceduresFunctional DisorderCardiovascular SystemAnimal ModelSignal TransductionAffectAortic ValveOxidative StressElderlyAortic Valve StenosisIn VivoAortic Valve DisorderInterstitial CellCalciumCalcifiedTherapeutic InterventionGene ExpressionTissuesPlasmaMolecularInnovative TherapyPlay

Grant awards (25)

Role of senescent cells in the pathogenesis of Marfan-associated cardiovascular disease$397,500
R01 · FY2021 · HL · contact PI
Role of senescent cells in the pathogenesis of Marfan-associated cardiovascular disease$397,500
R01 · FY2020 · HL · contact PI
Aging and Resiliency in Mice: Optimizing Assessment Protocols and Testing Interventions$396,364
R01 · FY2020 · AG
Role of senescent cells in the pathogenesis of Marfan-associated cardiovascular disease$397,500
R01 · FY2019 · HL · contact PI
Aging and Resiliency in Mice: Optimizing Assessment Protocols and Testing Interventions$396,040
R01 · FY2019 · AG
Role of senescent cells in the pathogenesis of Marfan-associated cardiovascular disease$397,500
R01 · FY2018 · HL · contact PI
Aging and Resiliency in Mice: Optimizing Assessment Protocols and Testing Interventions$395,840
R01 · FY2018 · AG
Role of SIRT6 in calcific aortic valve disease$397,500
R01 · FY2017 · HL · contact PI
Aging and Resiliency in Mice: Optimizing Assessment Protocols and Testing Interventions$394,229
R01 · FY2017 · AG
Aging and Resiliency in Mice: Optimizing Assessment Protocols and Testing Interventions$410,025
R01 · FY2016 · AG
Role of SIRT6 in calcific aortic valve disease$397,500
R01 · FY2016 · HL · contact PI
Therapeutic Strategy to slow progression of calcific aortic valve stenosis$969,945
UH3 · FY2015 · TR · contact PI
Role of SIRT6 in calcific aortic valve disease$391,537
R01 · FY2015 · HL · contact PI
Therapeutic Strategy to slow progression of calcific aortic valve stenosis$681,374
UH3 · FY2014 · TR · contact PI
Role of SIRT6 in calcific aortic valve disease$389,550
R01 · FY2014 · HL · contact PI
Therapeutic Strategy to slow progression of calcific aortic valve stenosis$367,324
UH3 · FY2014 · TR · contact PI
Therapeutic Strategy to slow progression of calcific aortic valve stenosis$163,310
UH2 · FY2014 · TR · contact PI
Therapeutic Strategy to slow progression of calcific aortic valve stenosis$987,837
UH2 · FY2013 · TR · contact PI
Role of SIRT6 in calcific aortic valve disease$397,500
R01 · FY2013 · HL · contact PI
Oxidative stress and aortic valve disease$248,999
R00 · FY2011 · HL · contact PI
Oxidative stress and aortic valve disease$248,998
R00 · FY2010 · HL · contact PI
Oxidative stress and aortic valve disease$248,999
R00 · FY2009 · HL · contact PI
Oxidative stress and aortic valve disease$107,190
K99 · FY2008 · HL · contact PI
Superoxide and Vascular Function in Heart Failure$37,650
F32 · FY2007 · HL · contact PI
Superoxide and Vascular Function in Heart Failure$46,745
F32 · FY2006 · HL · contact PI